Altamira Therapeutics Ltd. Revenue
Altamira Therapeutics Ltd. (CYTOF) reported Revenue of CHF 105.47 thousand for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-12.
Discontinued › Income Statement › Other Income
ifrs-full:Revenue · last filed 2023-09-12
| Period end | Revenue 6 month | Revenue 6 month as first filed | Revenue 12 month |
|---|---|---|---|
| 2023-06-30 | 105.47K CHF 6-K · filed 2023-09-12 | ||
| 2022-12-31 | 305.62K CHF 20-F · filed 2023-05-16 | ||
| 2022-06-30 | 290.80K CHF 6-K · filed 2023-09-12 | 1.22M CHF 6-K · filed 2022-11-30 | |
| 2021-12-31 | 63.88K CHF 20-F · filed 2023-05-16 |